SRAX (SRAX) 10-Q 14 Aug 19 2019 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2019	Aug. 14, 2019
Document And Entity Information
Entity Registrant Name	SOCIAL REALITY, Inc.
Entity Central Index Key	0001538217
Document Type	10-Q
Document Period End Date	Jun. 30, 2019
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2019
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Incorporation State Country Code	DE
Entity File Number	001-37916
Entity Common Stock, Shares Outstanding		12,384,123

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 2,465,639	$ 2,784,865
Accounts receivable, net	780,187	1,828,940
Prepaid expenses	550,003	466,823
Other current assets	300,898	387,085
Total current assets	4,096,727	5,467,713
Non-current Assets:
Property and equipment, net	211,240	192,065
Goodwill	15,644,957	15,644,957
Intangible assets, net	1,811,044	1,762,605
Right-of-Use Asset - Long Term Portion	466,253
Other assets	107,454	51,153
Total non-current assets	18,240,948	17,650,780
Total assets	22,337,675	23,118,493
Current liabilities:
Accounts payable and accrued expenses	1,456,965	3,574,926
Debenture warrant liability	8,215,035	4,323,499
Leapfrog warrant liability	1,161,350	622,436
Derivative liability	902,915	496,260
Other current liabilities	894,686
Total current liabilities	12,630,951	9,017,121
Non-current liabilities:
Lease Obligation - Long Term Portion	326,471
Total non-current liabilities	326,471
Total liabilities	12,957,422	9,017,121
Commitments and contingencies (Note 11)
Stockholders' equity:
Preferred stock, authorized 50,000,000 shares, $0.001 par value, no shares issued or outstanding at June 30, 2019 and December 31, 2018, respectively
Common stock to be issued
Additional paid in capital	42,030,110	32,869,611
Accumulated deficit	(32,662,403)	(18,778,348)
Total stockholders' equity	9,380,253	14,101,372
Total liabilities and stockholders' equity	22,337,675	23,118,493
Common Class A [Member]
Stockholders' equity:
Common stock	12,546	10,109
Common Class B [Member]
Stockholders' equity:
Common stock

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2019	Dec. 31, 2018
Preferred Stock, shares authorized	50,000,000	50,000,000
Preferred Stock, par value per share	$ 0.001	$ 0.001
Preferred Stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common Class A [Member]
Common Stock, shares authorized	250,000,000	250,000,000
Common Stock, par value per share	$ 0.001	$ 0.001
Common Stock, shares issued	12,546,022	10,109,530
Common Stock, shares outstanding	12,546,022	10,109,530
Common Class B [Member]
Common Stock, shares authorized	9,000,000	9,000,000
Common Stock, par value per share	$ 0.001	$ 0.001
Common Stock, shares issued	0	0
Common Stock, shares outstanding	0	0

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Income Statement [Abstract]
Revenue	$ 904,222	$ 4,697,351	$ 1,495,977	$ 6,808,201
Cost of revenue	410,892	1,320,464	753,239	2,138,569
Gross profit	493,330	3,376,887	742,738	4,669,632
Operating expense:
General, selling and administrative expense	5,114,115	5,392,625	9,605,377	9,522,883
Loss from operations	(4,620,785)	(2,015,738)	(8,862,639)	(4,853,251)
Other income (expense):
Interest expense	(183,257)	(486,758)	(250,944)	(921,543)
Amortization of debt issuance costs		(482,588)		(918,254)
Total Interest Expense	(183,257)	(969,346)	(250,944)	(1,839,797)
Gain or (loss) on sale of Assets	(77,373)	(22,165)	395,106	(22,165)
Exchange Gain or Loss		(596)	13,509	(5,260)
Loss on repricing of equity warrants	(341,682)		(341,682)
Change in Fair Value of Warrant Liability	(2,875,554)	(1,013,565)	(4,837,405)	2,710,129
Other non-operating income / (expense)	(3,294,609)	(1,036,326)	(4,770,472)	2,682,704
Total other income / (expense)	(3,477,866)	(2,005,672)	(5,021,416)	842,907
Loss before provision for income taxes	(8,098,651)	(4,021,410)	(13,884,055)	(4,010,344)
Provision for income taxes
Net loss	$ (8,098,651)	$ (4,021,410)	$ (13,884,055)	$ (4,010,344)
Net loss per share, basic and diluted	$ (0.67)	$ (0.39)	$ (1.24)	$ (0.4)
Weighted average shares outstanding
Basic	12,129,787	10,213,618	11,210,810	10,126,247
Diluted	12,129,787	10,213,618	11,210,810	10,126,247

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHARHOLDERS' EQUITY (Unaudited) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Common stock to be issued [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2017		$ 9,911	$ 879,500	$ 32,546,820	$ (27,521,941)	$ 5,914,290
Balance, shares at Dec. 31, 2017		9,910,565	150,000
Stock based compensation		$ 129		286,001		286,130
Stock based compensation, shares		6,667
Common stock issued for services, shares		150,000
Shares issued for services		$ 150	$ (859,500)	859,350
Shares issued for services, shares		150,000	(150,000)
Common stock issued to directors		$ 23	$ (10,000)	39,977		30,000
Common stock issued to directors, shares		22,556
Net Income (Loss)					11,068	11,068
Balance at Mar. 31, 2018		$ 10,213	$ 10,000	33,732,148	(27,510,873)	6,241,488
Balance, shares at Mar. 31, 2018		10,089,788
Balance at Dec. 31, 2017		$ 9,911	$ 879,500	32,546,820	(27,521,941)	5,914,290
Balance, shares at Dec. 31, 2017		9,910,565	150,000
Exercise of warrants, shares		61,482
Loss on repricing of equity warrants
Net Income (Loss)						(4,010,344)
Balance at Jun. 30, 2018		$ 10,274	$ 869,500	33,918,216	(31,532,283)	3,265,706
Balance, shares at Jun. 30, 2018		10,151,270	150,000
Balance at Mar. 31, 2018		$ 10,213	$ 10,000	33,732,148	(27,510,873)	6,241,488
Balance, shares at Mar. 31, 2018		10,089,788
Exercise of warrants		$ 61		49,938		49,999
Exercise of warrants, shares		61,482
Loss on repricing of equity warrants
Stock based compensation				136,130		136,130
Stock based compensation, shares
Shares issued for services			$ 859,500			859,500
Shares issued for services, shares			150,000
Net Income (Loss)					(4,021,410)	(4,021,410)
Balance at Jun. 30, 2018		$ 10,274	$ 869,500	33,918,216	(31,532,283)	3,265,706
Balance, shares at Jun. 30, 2018		10,151,270	150,000
Balance at Dec. 31, 2018		$ 10,109		32,869,611	(18,778,348)	14,101,372
Balance, shares at Dec. 31, 2018		10,109,530
Share based compensation, related to employees				120,885		120,885
Net Income (Loss)					(5,785,404)	(5,785,404)
Balance at Mar. 31, 2019		$ 10,109		32,990,496	(24,563,752)	8,436,853
Balance, shares at Mar. 31, 2019		10,109,530
Balance at Dec. 31, 2018		$ 10,109		32,869,611	(18,778,348)	14,101,372
Balance, shares at Dec. 31, 2018		10,109,530
Sale of common stock and warrants for cash, shares		1,687,825
Exercise of warrants, shares		328,667
Loss on repricing of equity warrants						341,682
Share of common stock in private placement, shares		200,000
Net Income (Loss)						(13,884,055)
Balance at Jun. 30, 2019		$ 12,546		42,030,110	(32,662,403)	9,380,253
Balance, shares at Jun. 30, 2019		12,546,022
Balance at Mar. 31, 2019		$ 10,109		32,990,496	(24,563,752)	8,436,853
Balance, shares at Mar. 31, 2019		10,109,530
Share based compensation, related to employees				325,511		325,511
Sale of common stock and warrants for cash		$ 1,688		6,227,021		6,228,709
Sale of common stock and warrants for cash, shares		1,687,825
Exercise of warrants		$ 329		1,145,820		1,146,149
Exercise of warrants, shares		328,667
Shares issued as collateral		$ 220		(220)
Shares issued as collateral, shares		220,000
Loss on repricing of equity warrants				341,682		341,682
Share of common stock in private placement		$ 200		999,800		1,000,000
Share of common stock in private placement, shares		200,000
Net Income (Loss)					(8,098,651)	(8,098,651)
Balance at Jun. 30, 2019		$ 12,546		$ 42,030,110	$ (32,662,403)	$ 9,380,253
Balance, shares at Jun. 30, 2019		12,546,022

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash flows from operating activities
Net Income (loss)	$ (13,884,055)	$ (4,010,344)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Stock based compensation	446,395	1,161,760
Amortization of debt issuance costs		300,185
Accretion of debenture discount and warrants		618,069
Gain/Loss on valuation of warrant derivatives	4,837,406	(2,710,129)
Loss on repricing of equity warrants	341,682
Gain on sale of SRAXmd	(395,106)
Provision for bad debts	241,753	(5,426)
Depreciation expense	33,749	20,036
Amortization of intangibles	495,178	350,165
Changes in operating assets and liabilities:
Accounts receivable	807,000	1,630,258
Prepaid expenses	(83,480)	(47,061)
Other assets	29,886	(2,672)
Accounts payable and accrued expenses	(1,363,056)	2,140,856
Net cash used in operating activities	(8,492,648)	(554,303)
Cash flows from investing activities
Proceeds from SRAXmd	395,106
Purchase of equipment	(52,924)	(20,793)
Development of software	(543,617)	(451,168)
Net cash (used in) provided by investing activities	(201,435)	(471,961)
Cash flows from financing activities
Proceeds from the issuance of common stock units	7,228,709
Proceeds from the issuance of common stock in conjunction with warrant exercised	1,146,148	50,001
Net cash provided by financing activities	8,374,857	50,001
Net increase / (decrease) in cash and cash equivalents	(319,226)	(976,263)
Cash and cash equivalents, beginning of period	2,784,865	1,017,299
Cash and cash equivalents, end of period	2,465,639	41,036
Supplemental schedule of cash flow information
Cash paid for interest	100,278	313,791
Cash paid for taxes
Supplemental Schedule of noncash financing activities
Recorded right-of-use asset	(466,253)
Recorded lease obligation	466,253
Vesting of common stock award		150,000
Issuance of treasury shares for purposes of loan collateralization	220
Issuance of common stock to be issued		$ 869,500

BASIS OF PRESENTATION AND SIGNI

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNT POLICIES	6 Months Ended
	Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNT POLICIES	NOTE 1 – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNT POLICIES The accompanying unaudited interim condensed consolidated financial statements included herein have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. However, the Company believes that the disclosures are adequate to prevent the information presented from being misleading. These financial statements should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations and the financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K, which contains audited financial information for the two years in the period ended December 31, 2018. Description of Business We are a digital marketing and data technology company with tools to reach and reveal valuable audiences with marketing and advertising communication. Our machine-learning technology analyzes marketing data to identify brands and content owners' core consumers and their characteristics across marketing channels. In addition to our business services and technologies, we also operate a direct to consumer platform, BIGToken, which enables consumers to own, manage and sell access to their digital identity and data. This provides us with a direct consumer relationship and gives us valuable proprietary data. We derive our revenues from: · sales of digital advertising campaigns to advertising agencies and brands; · sales of media inventory through real-time bidding, or “RTB”, exchanges; · sale and licensing of our SRAX Social · creation of custom platforms for buying media on SRAX · sales of proprietary consumer data. The core elements of our business are: · Social Reality Ad Exchange or "SRAX" Real Time Bidding sell side and buy side representation SRAX · SRAXauto · SRAXcore is our generalized services and technologies supporting brands and agencies in data management, audience optimization, and multi-channel and omnichannel media and marketing services · SRAXshopper · SRAXir · BIGToken Basis of Presentation The accompanying unaudited condensed consolidated financial statements and notes thereto are unaudited. The unaudited interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC"). Certain information and note disclosures normally included in the Company’s annual financial statements have been condensed or omitted. The December 31, 2018 condensed balance sheet data was derived from financial statements, but does not include all disclosures required by GAAP. These interim financial statements, in the opinion of management, reflect all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim three and six month periods ended June 30, 2019 and 2018. The results for the three and six months ended June 30, 2019 are not necessarily indicative of the results to be expected for the full year ending December 31, 2019 or for any future period. These unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto for the year ended December 31, 2018, included in the Company's annual report on Form 10-K filed with the SEC on April 16, 2019. Uses and Sources of Liquidity – Going Concern Although we believe that the foregoing actions will assist with our liquidity needs during the 12 months following the issuance of the financial statements, there is no assurance that the outcome of our actions will result in liquidity. If we continue to experience operating losses, we may need to raise additional capital through the sale of our equity and/or debt securities. Although historically we have funded our operations through the sale of our debt and equity securities, there is no assurance that we will be able to raise additional capital or that if such capital is raised, it will be on favorable terms. A failure to generate additional liquidity could negatively impact our business, including our access to critical business services. Additionally, if we require additional capital and are not able to secure it, we may need to greatly curtail our current and planned business initiatives. In connection with preparing consolidated financial statements for the year ended December 31, 2018, management evaluated whether there were conditions and events, considered in the aggregate, that raised substantial doubt about the Company’s ability to continue as a going concern within one year from the date that the financial statements are issued. The Company considered the following: · Operating losses of $11,648,703 and $13,884,055 for the year ended December 31, 2018 and the year to date period ended June 30, 2019, respectively. · Negative cash flow from operating activities for 2019 and 2018. · At June 30, 2019 the Company had an accumulated deficit of $32,662,403. · Revenue decline in the six months period ended June 30, 2019 from the same period in the prior year of $5,312,224. Ordinarily, conditions or events that raise substantial doubt about an entity’s ability to continue as a going concern relate to the entity’s ability to meet its obligations as they become due. The Company evaluated its ability to meet its obligations as they become due within one year from the date that the financial statements are issued by considering the following: · The Company has no debt as of June 30, 2019 · The Company has historically raised funds from debt and equity financings. · The Company’s sale of the SRAXmd vertical for $43.5 million in consideration. · In 2018, the Company is in compliance with NASDAQ Capital Markets listing requirements. · In 2018, the Company redeemed $6.5 million of convertible debentures. · Revenue declines were largely the result of a strategic shift away from lower margin sales the produced little to no positive cash flow benefit for the Company. The Company will take the following actions if it starts to trend unfavorably to its internal profitability and cash flow projections, in order to mitigate conditions or events that would raise substantial doubt about its ability to continue as a going concern: · Raise additional capital through short-term loans. · Implement restructuring and cost reductions. · Raise additional capital through a private placement. · Secure a commercial bank line of credit. · Dispose of one or more product lines. · Sell or license intellectual property. At June 30, 2019 the Company had $2,465,639 in cash and cash equivalents and negative working capital of $8,534,224. Impact of Recently Issued Accounting Standards Leases In February 2016, the FASB issued ASU No. 2016-02 (“ASC 842”), Leases, to require lessees to recognize all leases, with certain exceptions, on the balance sheet, while recognition on the statement of operations will remain similar to current lease accounting. Subsequently, the FASB issued ASU No.2018-10, Codification Improvements to Topic 842, Leases, ASU No. 2018-11, Targeted Improvements, ASU No. 2018-20, Narrow-Scope Improvements for Lessors, and ASU 2019-01, Codification Improvements, to clarify and amend the guidance in ASU No. 2016-02. ASC 842 eliminates real estate-specific provisions and modifies certain aspects of lessor accounting. This standard is effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted. We are using a modified retrospective adoption approach, is required to recognize and measure leases existing at the beginning of the adoption period, with certain practical expedients available. We adopted the standard effective January 1, 2019. The standard allows a number of optional practical expedients to use for transition. The Company choose the certain practical expedients allowed under the transition guidance which permitted us to not to reassess any existing or expired contracts to determine if they contain embedded leases, to not to reassess our lease classification on existing leases, to account for lease and non-lease components as a single lease component for equipment leases, and whether initial direct costs previously capitalized would qualify for capitalization under FASB ASC 842. The new standard also provides practical expedients and recognition exemptions for an entity's ongoing accounting policy elections. The Company has elected the short-term lease recognition for all leases that qualify, which means that we do not recognize a ROU asset and lease liability for any lease with a term of twelve months or less. The most significant impact of adopting the standard was the recognition of ROU assets and lease liabilities for operating leases on the Company's consolidated balance sheet but it did not have an impact on the Company's consolidated statements of operations or consolidated statements of cash flows. We recorded a ROU and the related operating lease liability for our long-term facilities lease. The below table summarizes these lease asset and liability accounts presented on our accompanying Condensed Consolidated Balance Sheets: Operating Leases* Condensed Consolidated Balance Sheet Caption Balance as of June 30, Operating lease right-of-use assets - non-current Right of Use Asset $ 466,253 Operating lease liabilities - current Accrued liabilities $ 139,782 Operating lease liabilities - non-current Lease Obligation – Long-Term $ 326,471 Total operating lease liabilities $ 466,253 * As of June 30, 2019, we have no “finance leases” as defined in Topic 842 Components of Lease Expense We recognize lease expense on a straight-line basis over the term of our operating leases, as reported within “selling, general and administrative” expense on the accompanying Condensed Consolidated Statement of Operations. The components of our aggregate lease expense is summarized below: Three Months Ended Six Months Ended Operating lease cost 76,277 152,842 Variable lease cost — — Short-term lease cost — — Total lease cost 76,277 152,842 Weighted Average Remaining Lease Term and Applied Discount Rate Weighted Average Remaining Lease Term Weighted Average Discount Rate Operating leases as of June 30, 2019 4.25 years 18 % Future Contractual Lease Payments as of June 30, 2019 The below table summarizes our (i) minimum lease payments over the next five years, (ii) lease arrangement implied interest, and (iii) present value of future lease payments: Operating Leases - future payments 2019 (remaining) $ 81,609 2020 163,218 2021 163,218 2022 163,218 2023 133,296 Total future lease payments, undiscounted 704,559 Less: Implied interest (238,306 ) Present value of operating lease payments 466,253 Effective January 1, 2018, we adopted ASU No. 2016-15, Statement of Cash Flows (Topic 230) In February 2018, the FASB issued ASU 2018-02: Income Statement – Reporting Comprehensive Income (Topic 220) In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Changes to the Disclosure Requirements for Fair Value Measurement, Accounting Guidance Issued but Not Adopted at June 30, 2019 In August 2018, the FASB issued ASU 2018-13, "Fair Value Measurement (Topic 820): Disclosure Framework — In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Instruments." This ASU replaces the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information for credit loss estimates. In addition, new disclosures are required. The ASU is effective for fiscal years beginning after December 15, 2019. We are currently evaluating the impact of adopting this guidance. During the six months ended June 30, 2019, the Financial Accounting Standards Board (“FASB”) has not issued any Accounting Standard Updates which are expected to have a material retrospective or future effect on the consolidated financial statements.

WARRANT LIABILITIES

WARRANT LIABILITIES	6 Months Ended
	Jun. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
WARRANT LIABILITIES	NOTE 2 – WARRANT LIABILITIES The discussion below relates to the following (collectively, the “Derivative Warrant Instruments”): 1. In January 2017, the Company issued Series A and Series B Warrants in our registered direct and concurrent private placement. In April 2017, the Company repurchased the Series B Warrants for $2,500,000 and recognized a loss on the repurchase amounting to $2,053,975. Accordingly, only the Series A Warrants are currently outstanding. 2. In April and October 2017, the Company issued the Series A1 Warrants and Series A2 Warrants in connection with the private placement of secured convertible debentures; and 3. In November 2018, the Company issued the Series B1 Warrants upon redemption of the outstanding convertible debentures issued in April and October 2017, pursuant to the terms of such debentures. The Derivative Warrant Instruments have been accounted for utilizing ASC 815 “Derivatives and Hedging”. The Company identified embedded features in the Derivative Warrant Instruments which caused the warrants to be classified as a liability. These embedded features included the right for the holders to request for the Company to cash settle the Warrant Instruments from the Holder by paying to the Holder an amount of cash equal to the Black-Scholes value of the remaining unexercised portion of the Derivative Warrant Instruments on the date of the consummation of a fundamental transaction. The accounting treatment of derivative financial instruments requires that the Company treat the whole instrument as liability and record the fair value of the instrument as a derivative as of the inception date of the instrument and to adjust the fair value of the instrument as of each subsequent balance sheet dates. The Warrant liabilities are comprised of the following at June 30: Debenture Warrant Liability Leapfrog Warrant Liability Derivative Liability Balance as of beginning of period (December 31, 2018) 4,323,357 622,296 496,241 Adjustments to Warrants Outstanding — — — Adjustment to fair value 1,577,865 208,072 175,914 Balance as of end of period (March 31, 2019) 5,901,222 830,368 672,155 Adjustments to Warrants Outstanding — — — Adjustment to fair value 2,313,813 330,982 230,760 Balance as of end of period (June 30, 2019) 8,215,035 1,161,350 902,915 Debenture Warrant Liability Leapfrog Warrant Liability Derivative Liability Balance as of beginning of period (December 31, 2017) 7,256,864 1,873,107 2,026,031 Adjustments to Warrants Outstanding — — — Adjustment to fair value (2,409,444 ) (629,171 ) (685,080 ) Balance as of end of period (March 31, 2018) 4,847,420 1,243,936 1,340,951 Adjustments to Warrants Outstanding — — (328,627 ) Adjustment to fair value 862,115 269,127 210,950 Balance as of end of period (June 30, 2018) 5,709,535 1,513,063 1,223,274

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	6 Months Ended
	Jun. 30, 2019
Stockholders' Equity Note [Abstract]
STOCKHOLDERS' EQUITY	NOTE 3 – STOCKHOLDERS' EQUITY Stock Awards During the year ended December 31, 2018 and as of June 30, 2019, respectively, we issued a 75,000 share stock grant to a contractor during the three months ended June 30, 2019. Stock Options During the three month period ended June 30, 2019 the Company issued 11,252 options to purchase the Company’s common stock at a price of $5.49 to our non-executive directors. Each of our four non-executive directors received 2,813 options that vest 1/4 th On March 27, 2019, 685,000 common stock options having an exercise price of $3.42 per share with an option value as of the grant date of $1,513,137 calculated using the Black-Scholes option pricing model were granted to several employees and members of our management team. This expense associated with this option award will be recognized in operating expenses ratably over the vesting period. The expected option life assumption is estimated based on the simplified method. Accordingly, the Company has utilized the average of the contractual term of the options and the weighted average vesting period for all options to calculate the expected option term. The risk-free interest rate assumption is based upon observed interest rates appropriate for the expected term of our employee stock options. In April 2019, the Company amended its expected volatility assumption from using exclusively a historical volatility. The Company calculates its expected volatility assumption based on a its historical and implied volatilities over the expected life of the stock-based award. We do not anticipate paying dividends on the common stock in the foreseeable future. We recognize stock-based compensation expense over the vesting period using the straight-line single option method. Stock-based compensation expense is recognized only for those awards that vest. We account for the forfeitures of unvested awards as they occur. Total stock-based compensation expense for the three month period ended June 30, 2019 and 2018 was $326,000 and $996,000, respectively. Total stock-based compensation expense for the six month period ended June 30, 2019 and 2018 was $466,000 and $1,162,000, respectively. The expense is included in its entirety within General, selling and administrative expenses. Transactions involving our stock options for the year to date period ending June 30, 2019 are summarized as follows: Number of Shares Weighted Average Strike Price/Share Weighted Average Remaining Contractual Term ( Years) Aggregate Intrinsic Value Outstanding — December 31, 2018 547,662 $ 5.27 2.7 $ — Granted (weighted-average fair value of $2.21 per share) 696,252 3.45 3.0 842,465 Exercised — — — — Forfeited (2,400 ) 13.50 — — Outstanding — June 30, 2019 1,241,514 4.24 2.3 521,436 Vested (exercisable) — June 30, 2019 348,933 6.15 2.3 — Expected to vest after June 30, 2019 (unexercisable) 892,581 $ 3.49 2.3 $ 1,044,320 (1) Aggregate intrinsic value represents the difference between the exercise price of the option and the closing market price of our common stock on June 28, 2019, which was $4.66 per share Warrants On May 13, 2019 the Company entered into a consulting agreement with a contractor for services related to BIGtoken. The agreement provides for 300,000 warrants with vesting conditions based on BIGtoken user growth in Asia. The warrants were valued using the Black Scholes option pricing model at a total of $1,138,332 based on the five-year term, implied volatility of 101%, a risk free equivalent yield of 1.8% and stock price of $4.99. We typically issue warrants to purchase shares of our common stock to investors as part of a financing transaction or in connection with services rendered by placement agents and consultants. Our outstanding warrants expire on varying dates through November 2021. A summary of warrant activity is as follows: Transactions involving our stock warrants for the year to date period ended June 30, 2019 include the following: Number of Shares Weighted Average Strike Price/Share Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding — December 31, 2018 4,325,423 $ 3.77 2.9 $ 3,849,626 Granted 399,610 4.81 5.0 — Exercised (328,667 ) 3.49 0.3 384,540 Forfeited — — — Outstanding — June 30, 2019 4,396,366 3.90 2.7 3,341,238 Vested (exercisable) — June 30, 2019 4,096,366 3.83 2.6 3,399,984 Expected to vest after June 30, 2019 (unexercisable) 300,000 $ 5.00 4.8 $ — The fair value of each warrant grant was estimated on the date of grant using Black-Scholes with the following weighted average assumptions: Expected life (years) 1 - 7 Risk-free interest rate 1.31% - 2.3% Volatility 100% - 167% Dividend yield 0% (1) Aggregate intrinsic value represents the difference between the exercise price of the warrant and the closing market price of our common stock on June 28, 2019, which was $4.66 per share. Total intrinsic value of warrants exercised during the three and six months ended June 30, 2019 was $345,776. Loss per share As the Company incurred a net loss during the six months ended June 30, 2019, and during the three months ended June 30, 2019, the loss and diluted loss per common share are based on the weighted-average common shares outstanding during the period, accordingly the company had no dilutive securities during the three and six months ended June 30, 2019 and 2018. The following outstanding instruments could have a dilutive effect in the future: June 30, June 30 (unaudited) (unaudited) Warrants 4,396,366 2,196,700 Stock options 1,241,514 370,600 Total 5,637,880 2,567,300 The following transactions during the three and six months ended June 30, 2019 impacted the shares outstanding: · 1,687,825 shares of common stock in a registered direct offering in April 2019. · 328,667 shares from the exercise of warrants · 200,000 shares in a private placement of shares The following transactions during the three and six months ended June 30, 2018 impacted the shares outstanding: · 61,482 share from the exercise of warrants · 150,000 shares issued to a contractor for services · 29,223 shares as compensation to employees and directors

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2019
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 4 – COMMITMENTS AND CONTINGENCIES BIGtoken Point liability During the three and six months ended June 30, 2019 the Company instituted a policy that allows BIGtoken user to redeem outstanding BIGtoken points for cash if their account and point balances meet certain criteria. As of June 30, 2019, the Company has estimated the future liability for point redemptions to be $187,000. The Company considered the total number of points outstanding, the conversion rate in which points are redeemable for cash. Due to the recency of the BIGtoken platform and the ability for users to redeem points for cash, the Company does not have sufficient history to estimate account attrition and the associate breakage rates for outstanding points. Therefore, the Company utilized a breakage factor of zero percent as of June 30, 2019 in determining the estimated liability.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2019
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 5 – SUBSEQUENT EVENTS On August 12, 2019, the Company entered into an agreement with existing investors to purchase 1,525,000 shares of class A common stock and Series A warrants to purchase an aggregate of 965,500 shares of common stock at $3.60 per share in registered direct offering. The Series A warrants are exercisable for 90 days at an exercise price of $3.60. Social Reality has also agreed to issue to the investors in a concurrent private placement Series B warrants to purchase an aggregate of 1,525,000 shares of common stock and Series C warrants to purchase an aggregate of 965,500 shares of common stock that each are exercisable six months following issuance, are exercisable until October 1, 2022, and have an exercise price of $4.00. The Series C warrants vest ratably upon the exercise of the Series A warrants. The closing of the offering is expected to take place on or about August 14, 2019, subject to the satisfaction of customary closing conditions.

BASIS OF PRESENTATION AND SIG_2

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNT POLICIES (Policies)	6 Months Ended
	Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business	Description of Business We are a digital marketing and data technology company with tools to reach and reveal valuable audiences with marketing and advertising communication. Our machine-learning technology analyzes marketing data to identify brands and content owners' core consumers and their characteristics across marketing channels. In addition to our business services and technologies, we also operate a direct to consumer platform, BIGToken, which enables consumers to own, manage and sell access to their digital identity and data. This provides us with a direct consumer relationship and gives us valuable proprietary data. We derive our revenues from: · sales of digital advertising campaigns to advertising agencies and brands; · sales of media inventory through real-time bidding, or “RTB”, exchanges; · sale and licensing of our SRAX Social · creation of custom platforms for buying media on SRAX · sales of proprietary consumer data. The core elements of our business are: · Social Reality Ad Exchange or "SRAX" Real Time Bidding sell side and buy side representation SRAX · SRAXauto · SRAXcore is our generalized services and technologies supporting brands and agencies in data management, audience optimization, and multi-channel and omnichannel media and marketing services · SRAXshopper · SRAXir · BIGToken
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements and notes thereto are unaudited. The unaudited interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC"). Certain information and note disclosures normally included in the Company’s annual financial statements have been condensed or omitted. The December 31, 2018 condensed balance sheet data was derived from financial statements, but does not include all disclosures required by GAAP. These interim financial statements, in the opinion of management, reflect all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim three and six month periods ended June 30, 2019 and 2018. The results for the three and six months ended June 30, 2019 are not necessarily indicative of the results to be expected for the full year ending December 31, 2019 or for any future period. These unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto for the year ended December 31, 2018, included in the Company's annual report on Form 10-K filed with the SEC on April 16, 2019.
Uses and Sources of Liquidity	Uses and Sources of Liquidity – Going Concern Although we believe that the foregoing actions will assist with our liquidity needs during the 12 months following the issuance of the financial statements, there is no assurance that the outcome of our actions will result in liquidity. If we continue to experience operating losses, we may need to raise additional capital through the sale of our equity and/or debt securities. Although historically we have funded our operations through the sale of our debt and equity securities, there is no assurance that we will be able to raise additional capital or that if such capital is raised, it will be on favorable terms. A failure to generate additional liquidity could negatively impact our business, including our access to critical business services. Additionally, if we require additional capital and are not able to secure it, we may need to greatly curtail our current and planned business initiatives. In connection with preparing consolidated financial statements for the year ended December 31, 2018, management evaluated whether there were conditions and events, considered in the aggregate, that raised substantial doubt about the Company’s ability to continue as a going concern within one year from the date that the financial statements are issued. The Company considered the following: · Operating losses of $11,648,703 and $13,884,055 for the year ended December 31, 2018 and the year to date period ended June 30, 2019, respectively. · Negative cash flow from operating activities for 2019 and 2018. · At June 30, 2019 the Company had an accumulated deficit of $32,662,403. · Revenue decline in the six months period ended June 30, 2019 from the same period in the prior year of $5,312,224. Ordinarily, conditions or events that raise substantial doubt about an entity’s ability to continue as a going concern relate to the entity’s ability to meet its obligations as they become due. The Company evaluated its ability to meet its obligations as they become due within one year from the date that the financial statements are issued by considering the following: · The Company has no debt as of June 30, 2019 · The Company has historically raised funds from debt and equity financings. · The Company’s sale of the SRAXmd vertical for $43.5 million in consideration. · In 2018, the Company is in compliance with NASDAQ Capital Markets listing requirements. · In 2018, the Company redeemed $6.5 million of convertible debentures. · Revenue declines were largely the result of a strategic shift away from lower margin sales the produced little to no positive cash flow benefit for the Company. The Company will take the following actions if it starts to trend unfavorably to its internal profitability and cash flow projections, in order to mitigate conditions or events that would raise substantial doubt about its ability to continue as a going concern: · Raise additional capital through short-term loans. · Implement restructuring and cost reductions. · Raise additional capital through a private placement. · Secure a commercial bank line of credit. · Dispose of one or more product lines. · Sell or license intellectual property. At June 30, 2019 the Company had $2,465,639 in cash and cash equivalents and negative working capital of $8,534,224.
Impact of Recently Issued Accounting Standards	Impact of Recently Issued Accounting Standards Leases In February 2016, the FASB issued ASU No. 2016-02 (“ASC 842”), Leases, to require lessees to recognize all leases, with certain exceptions, on the balance sheet, while recognition on the statement of operations will remain similar to current lease accounting. Subsequently, the FASB issued ASU No.2018-10, Codification Improvements to Topic 842, Leases, ASU No. 2018-11, Targeted Improvements, ASU No. 2018-20, Narrow-Scope Improvements for Lessors, and ASU 2019-01, Codification Improvements, to clarify and amend the guidance in ASU No. 2016-02. ASC 842 eliminates real estate-specific provisions and modifies certain aspects of lessor accounting. This standard is effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted. We are using a modified retrospective adoption approach, is required to recognize and measure leases existing at the beginning of the adoption period, with certain practical expedients available. We adopted the standard effective January 1, 2019. The standard allows a number of optional practical expedients to use for transition. The Company choose the certain practical expedients allowed under the transition guidance which permitted us to not to reassess any existing or expired contracts to determine if they contain embedded leases, to not to reassess our lease classification on existing leases, to account for lease and non-lease components as a single lease component for equipment leases, and whether initial direct costs previously capitalized would qualify for capitalization under FASB ASC 842. The new standard also provides practical expedients and recognition exemptions for an entity's ongoing accounting policy elections. The Company has elected the short-term lease recognition for all leases that qualify, which means that we do not recognize a ROU asset and lease liability for any lease with a term of twelve months or less. The most significant impact of adopting the standard was the recognition of ROU assets and lease liabilities for operating leases on the Company's consolidated balance sheet but it did not have an impact on the Company's consolidated statements of operations or consolidated statements of cash flows. We recorded a ROU and the related operating lease liability for our long-term facilities lease. The below table summarizes these lease asset and liability accounts presented on our accompanying Condensed Consolidated Balance Sheets: Operating Leases* Condensed Consolidated Balance Sheet Caption Balance as of June 30, Operating lease right-of-use assets - non-current Right of Use Asset $ 466,253 Operating lease liabilities - current Accrued liabilities $ 139,782 Operating lease liabilities - non-current Lease Obligation – Long-Term $ 326,471 Total operating lease liabilities $ 466,253 * As of June 30, 2019, we have no “finance leases” as defined in Topic 842 Components of Lease Expense We recognize lease expense on a straight-line basis over the term of our operating leases, as reported within “selling, general and administrative” expense on the accompanying Condensed Consolidated Statement of Operations. The components of our aggregate lease expense is summarized below: Three Months Ended Six Months Ended Operating lease cost 76,277 152,842 Variable lease cost — — Short-term lease cost — — Total lease cost 76,277 152,842 Weighted Average Remaining Lease Term and Applied Discount Rate Weighted Average Remaining Lease Term Weighted Average Discount Rate Operating leases as of June 30, 2019 4.25 years 18 % Future Contractual Lease Payments as of June 30, 2019 The below table summarizes our (i) minimum lease payments over the next five years, (ii) lease arrangement implied interest, and (iii) present value of future lease payments: Operating Leases - future payments 2019 (remaining) $ 81,609 2020 163,218 2021 163,218 2022 163,218 2023 133,296 Total future lease payments, undiscounted 704,559 Less: Implied interest (238,306 ) Present value of operating lease payments 466,253 Effective January 1, 2018, we adopted ASU No. 2016-15, Statement of Cash Flows (Topic 230) In February 2018, the FASB issued ASU 2018-02: Income Statement – Reporting Comprehensive Income (Topic 220) In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Changes to the Disclosure Requirements for Fair Value Measurement, Accounting Guidance Issued but Not Adopted at June 30, 2019 In August 2018, the FASB issued ASU 2018-13, "Fair Value Measurement (Topic 820): Disclosure Framework — In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Instruments." This ASU replaces the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information for credit loss estimates. In addition, new disclosures are required. The ASU is effective for fiscal years beginning after December 15, 2019. We are currently evaluating the impact of adopting this guidance. During the six months ended June 30, 2019, the Financial Accounting Standards Board (“FASB”) has not issued any Accounting Standard Updates which are expected to have a material retrospective or future effect on the consolidated financial statements.

BASIS OF PRESENTATION AND SIG_3

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNT POLICIES (Tables)	6 Months Ended
	Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Lease Asset and Liability Accounts Presented in Condensed Consolidated Balance Sheets	The below table summarizes these lease asset and liability accounts presented on our accompanying Condensed Consolidated Balance Sheets: Operating Leases* Condensed Consolidated Balance Sheet Caption Balance as of June 30, Operating lease right-of-use assets - non-current Right of Use Asset $ 466,253 Operating lease liabilities - current Accrued liabilities $ 139,782 Operating lease liabilities - non-current Lease Obligation – Long-Term $ 326,471 Total operating lease liabilities $ 466,253 * As of June 30, 2019, we have no “finance leases” as defined in Topic 842
Schedule of Component of Lease Expense	The components of our aggregate lease expense is summarized below: Three Months Ended Six Months Ended Operating lease cost 76,277 152,842 Variable lease cost — — Short-term lease cost — — Total lease cost 76,277 152,842
Schedule of Weighted Average Remaining Lease Term and Applied Discount Rate	Weighted Average Remaining Lease Term and Applied Discount Rate Weighted Average Remaining Lease Term Weighted Average Discount Rate Operating leases as of June 30, 2019 4.25 years 18 %
Schedule of Future Contractual Lease Payments	The below table summarizes our (i) minimum lease payments over the next five years, (ii) lease arrangement implied interest, and (iii) present value of future lease payments: Operating Leases - future payments 2019 (remaining) $ 81,609 2020 163,218 2021 163,218 2022 163,218 2023 133,296 Total future lease payments, undiscounted 704,559 Less: Implied interest (238,306 ) Present value of operating lease payments 466,253

WARRANT LIABILITY (Tables)

WARRANT LIABILITY (Tables)	6 Months Ended
	Jun. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Warrant Liability	The Warrant liabilities are comprised of the following at June 30: Debenture Warrant Liability Leapfrog Warrant Liability Derivative Liability Balance as of beginning of period (December 31, 2018) 4,323,357 622,296 496,241 Adjustments to Warrants Outstanding — — — Adjustment to fair value 1,577,865 208,072 175,914 Balance as of end of period (March 31, 2019) 5,901,222 830,368 672,155 Adjustments to Warrants Outstanding — — — Adjustment to fair value 2,313,813 330,982 230,760 Balance as of end of period (June 30, 2019) 8,215,035 1,161,350 902,915 Debenture Warrant Liability Leapfrog Warrant Liability Derivative Liability Balance as of beginning of period (December 31, 2017) 7,256,864 1,873,107 2,026,031 Adjustments to Warrants Outstanding — — — Adjustment to fair value (2,409,444 ) (629,171 ) (685,080 ) Balance as of end of period (March 31, 2018) 4,847,420 1,243,936 1,340,951 Adjustments to Warrants Outstanding — — (328,627 ) Adjustment to fair value 862,115 269,127 210,950 Balance as of end of period (June 30, 2018) 5,709,535 1,513,063 1,223,274

STOCKHOLDERS' EQUITY (Tables)

STOCKHOLDERS' EQUITY (Tables)	6 Months Ended
	Jun. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Loss Per Share Dilutive Effect	The following outstanding instruments could have a dilutive effect in the future: June 30, June 30 (unaudited) (unaudited) Warrants 4,396,366 2,196,700 Stock options 1,241,514 370,600 Total 5,637,880 2,567,300
Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of stock options and stock warrants	Transactions involving our stock options for the year to date period ending June 30, 2019 are summarized as follows: Number of Shares Weighted Average Strike Price/Share Weighted Average Remaining Contractual Term ( Years) Aggregate Intrinsic Value Outstanding — December 31, 2018 547,662 $ 5.27 2.7 $ — Granted (weighted-average fair value of $2.21 per share) 696,252 3.45 3.0 842,465 Exercised — — — — Forfeited (2,400 ) 13.50 — — Outstanding — June 30, 2019 1,241,514 4.24 2.3 521,436 Vested (exercisable) — June 30, 2019 348,933 6.15 2.3 — Expected to vest after June 30, 2019 (unexercisable) 892,581 $ 3.49 2.3 $ 1,044,320
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of stock options and stock warrants	Transactions involving our stock warrants for the year to date period ended June 30, 2019 include the following: Number of Shares Weighted Average Strike Price/Share Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding — December 31, 2018 4,325,423 $ 3.77 2.9 $ 3,849,626 Granted 399,610 4.81 5.0 — Exercised (328,667 ) 3.49 0.3 384,540 Forfeited — — — Outstanding — June 30, 2019 4,396,366 3.90 2.7 3,341,238 Vested (exercisable) — June 30, 2019 4,096,366 3.83 2.6 3,399,984 Expected to vest after June 30, 2019 (unexercisable) 300,000 $ 5.00 4.8 $ —
Schedule of Fair Value of Warrant Weighted Average Assumptions	The fair value of each warrant grant was estimated on the date of grant using Black-Scholes with the following weighted average assumptions: Expected life (years) 1 - 7 Risk-free interest rate 1.31% - 2.3% Volatility 100% - 167% Dividend yield 0

BASIS OF PRESENTATION AND SIG_4

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNT POLICIES (Narrative) (Details) - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2018	Mar. 31, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018	Dec. 31, 2017
General, selling and administrative expense	$ 5,114,115		$ 5,392,625		$ 9,605,377	$ 9,522,883
Net Income (loss)	(8,098,651)	$ (5,785,404)	(4,021,410)	$ 11,068	(13,884,055)	(4,010,344)
Accumulated deficit	32,662,403		27,510,876		32,662,403	27,510,876	$ 18,778,348
Cash and cash equivalents	2,465,639		$ 41,036		2,465,639	$ 41,036	2,784,865	$ 1,017,299
Working capital deficit	8,534,224				8,534,224		3,549,408
Operating losses					13,884,055		11,648,703
Decline in revenue from preceding period					5,312,224
Negative working capital	$ 8,533,924				8,533,924
Convertible debentures redeemed							$ 6,500,000
SRAXmd [Member]
Consideration					$ 43,500,000

BASIS OF PRESENTATION AND SIG_5

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNT POLICIES (Schedule of Lease Asset and Liability Accounts) (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Operating Leases
Operating lease right-of-use assets - non-current	$ 466,253
Operating lease liabilities - current	139,782
Operating lease liabilities - non-current	326,471
Total operating lease liabilities	$ 466,253

BASIS OF PRESENTATION AND SIG_6

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNT POLICIES (Schedule of Component of Lease Expense) (Details) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Operating lease cost	$ 76,277	$ 152,842
Variable lease cost
Short-term lease cost
Total lease costs	$ 76,277	$ 152,842

BASIS OF PRESENTATION AND SIG_7

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNT POLICIES (Schedule of Weighted Average Remaining Lease Term) (Details)	Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Weighted average remaining lease term	4 years 2 months 30 days
Weighted average discount rate	18.00%

BASIS OF PRESENTATION AND SIG_8

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNT POLICIES (Schedule of Future Contractual Lease Payments) (Details)	Jun. 30, 2019USD ($)
Operating Leases - future payments
2019 (remaining)	$ 81,609
2020	163,218
2021	163,218
2022	163,218
2023	133,296
Total future lease payments, undiscounted	704,559
Less: Implied interest	(238,306)
Total operating lease liabilities	$ 466,253

WARRANT LIABILITIES (Narrative)

WARRANT LIABILITIES (Narrative) (Details) - Series B Warrants [Member]	1 Months Ended
	Apr. 30, 2017USD ($)
Class of Warrant or Right [Line Items]
Repurchase of warrant	$ 2,500,000
Loss on repurchase of stock	$ 2,053,975

WARRANT LIABILITIES (Summary of

WARRANT LIABILITIES (Summary of Warrant Liabilities) (Details) - USD ($)	3 Months Ended
	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2018	Mar. 31, 2018
Debenture Warrant Liability [Member]
Class of Warrant or Right [Line Items]
Balance as of beginning of period	$ 5,901,222	$ 4,323,357	$ 4,847,420	$ 7,256,864
Adjustments to Warrants Outstanding
Adjustment to fair value	2,313,813	1,577,865	862,115	(2,409,444)
Balance as of end of period	8,215,035	5,901,222	5,709,535	4,847,420
Leapfrog Warrant Liability [Member]
Class of Warrant or Right [Line Items]
Balance as of beginning of period	830,368	622,296	1,243,936	1,873,107
Adjustments to Warrants Outstanding
Adjustment to fair value	330,982	208,072	269,127	(629,171)
Balance as of end of period	1,161,350	830,368	1,513,063	1,243,936
Derivative Liability [Member]
Class of Warrant or Right [Line Items]
Balance as of beginning of period	672,155	496,241	1,340,951	2,026,031
Adjustments to Warrants Outstanding			(328,627)
Adjustment to fair value	230,760	175,914	210,950	(685,080)
Balance as of end of period	$ 902,915	$ 672,155	$ 1,223,274	$ 1,340,951

STOCKHOLDERS' EQUITY (Narrative

STOCKHOLDERS' EQUITY (Narrative) (Details) - USD ($)	May 13, 2019	Mar. 27, 2019	Jun. 30, 2019	Jun. 30, 2018	Mar. 31, 2018	Jun. 30, 2019	Jun. 30, 2018
Stock Option [Member]
Option granted		685,000				696,252
Per share price		$ 3.42				$ 3.45
Weighted average fair value per share						$ 2.21
Option value		$ 1,513,137
Stock-based compensation expense			$ 326,000	$ 996,000		$ 466,000	$ 1,162,000
Aggregate instrinsic value of exercise price						$ 4.66
Stock Option [Member] | Contractor [Member]
Option granted			75,000
Stock Option [Member] | Non-Executive Directors [Member]
Option granted			11,252
Per share price			$ 5.49
Option Expired			Apr. 15, 2026
Option value			$ 60,000
Expected term			7 years
Volatility rate			102.00%
Risk free yield			2.46%
Stock price			$ 5.49			$ 5.49
Stock Option [Member] | Non-Executive Directors One [Member]
Option granted			2,813
Stock Option [Member] | Non-Executive Directors Two [Member]
Option granted			2,813
Stock Option [Member] | Non-Executive Directors Three [Member]
Option granted			2,813
Stock Option [Member] | Non-Executive Directors Four [Member]
Option granted			2,813
Warrant [Member]
Option granted	300,000
Option Expired						Nov. 30, 2021
Option value	$ 1,138,332
Expected term	5 years
Volatility rate	101.00%
Risk free yield	1.80%
Stock price	$ 4.99
Aggregate instrinsic value of exercise price						$ 4.66
Intrinsic value of warrants exercised			$ 345,776			$ 345,776
Common Stock [Member]
Sale of common stock and warrants for cash, shares			1,687,825			1,687,825
Exercise of warrants, shares			328,667	61,482		328,667	61,482
Share of common stock in private placement, shares			200,000			200,000
Common stock issued for services, shares					150,000
Shares as compensation to employees and directors, shares				29,223			29,223

STOCKHOLDERS' EQUITY (Summary o

STOCKHOLDERS' EQUITY (Summary of Stock Options Activity) (Details) - Stock Option [Member] - USD ($)	1 Months Ended	6 Months Ended	12 Months Ended
	Mar. 27, 2019	Jun. 30, 2019	Dec. 31, 2018
Options
Outstanding - December 31, 2018		547,662
Granted (weighted-average fair value of $2.21 per share)	685,000	696,252
Exercised
Forfeited		(2,400)
Outstanding - June 30, 2019		1,241,514	547,662
Vested (exercisable) - June 30, 2019		348,933
Expected to vest after June 30, 2019 (unexercisable)		892,581
Weighted Average Exercise Price
Outstanding - December 31, 2018		$ 5.27
Granted (weighted-average fair value of $2.21 per share)	$ 3.42	3.45
Exercised
Forfeited		13.50
Outstanding - June 30, 2019		4.24	$ 5.27
Vested (exercisable) - June 30, 2019		6.15
Expected to vest after June 30, 2019 (unexercisable)		$ 3.49
Weighted Average Remaining Contractual Term ( Years)
Outstanding - December 31, 2018		2 years 3 months 19 days	2 years 8 months 12 days
Granted (weighted-average fair value of $2.21 per share)		3 years
Vested (exercisable) - June 30, 2019		2 years 3 months 19 days
Expected to vest after June 30, 2019 (unexercisable)		2 years 3 months 19 days
Aggregate Intrinsic Value
Outstanding - December 31, 2018
Granted (weighted-average fair value of $2.21 per share)		$ 842,465
Exercised
Outstanding - June 30, 2019		521,436
Expected to vest after June 30, 2019 (unexercisable)		$ 1,044,320

STOCKHOLDERS' EQUITY (Summary_2

STOCKHOLDERS' EQUITY (Summary of Stock Warrants Activity) (Details) - Warrant [Member] - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2019	Dec. 31, 2018
Warrant activity, number of shares:
Outstanding - December 31, 2018	4,325,423
Granted	399,610
Exercised	(328,667)
Forfeited
Outstanding - June 30, 2019	4,396,366	4,325,423
Vested (exercisable) - June 30, 2019	4,096,366
Expected to vest after June 30, 2019 (unexercisable)	300,000
Warrant activity, weighted average exercise price:
Outstanding - December 31, 2018	$ 3.77
Granted	4.81
Exercised	3.49
Outstanding - June 30, 2019	3.90	$ 3.77
Vested (exercisable) - June 30, 2019	3.83
Expected to vest after June 30, 2019 (unexercisable)	$ 5
Weighted Average Remaining Contractual Term ( Years)
Outstanding - December 31, 2018	2 years 26 days	2 years 10 months 25 days
Granted	5 years
Exercised	3 months 19 days
Vested (exercisable) - June 30, 2019	2 years 22 days
Expected to vest after June 30, 2019 (unexercisable)	4 years 29 days
Aggregate Intrinsic Value
Outstanding - December 31, 2018	$ 3,849,626
Granted
Exercised	$ 384,540
Outstanding - June 30, 2019	3,341,238	$ 3,849,626
Vested (exercisable) - June 30, 2019	3,399,984
Expected to vest after June 30, 2019 (unexercisable)

STOCKHOLDERS' EQUITY (Schedule

STOCKHOLDERS' EQUITY (Schedule of Fair Value of Warrant Weighted Average Assumptions) (Details) - Warrant [Member]	May 13, 2019	Jun. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life (years)	5 years
Risk-free interest rate, Minimum		1.31%
Risk-free interest rate, Maximum		2.30%
Volatility Minimum		100.00%
Volatility Maximum		167.00%
Dividend yield		0.00%
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life (years)		1 year
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life (years)		7 years

STOCKHOLDERS' EQUITY (Schedul_2

STOCKHOLDERS' EQUITY (Schedule of Loss Per Share Dilutive Effect) (Details) - shares	3 Months Ended	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dilutive effect	5,637,880	2,567,300
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dilutive effect	4,396,366	2,196,700
Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dilutive effect	1,241,514	370,600

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details)	Jun. 30, 2019USD ($)
Commitments and Contingencies Disclosure [Abstract]
Future liability for point redemptions	$ 187,000

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - Subsequent Event [Member]	Aug. 12, 2019$ / sharesshares
Series A Warrants [Member]
Subsequent Event [Line Items]
Option granted	965,500
Per share price | $ / shares	$ 3.60
Series B Warrants [Member]
Subsequent Event [Line Items]
Option granted	1,525,000
Per share price | $ / shares	$ 4
Exercisable date	Oct. 1, 2022
Series C Warrants [Member]
Subsequent Event [Line Items]
Option granted	965,500
Per share price | $ / shares	$ 4
Exercisable date	Oct. 1, 2022
Common Class A [Member]
Subsequent Event [Line Items]
Option granted	1,525,000